Insiders Corcept Therapeutics Incorporated

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 28/06/2024 BST			5-day change	1st Jan Change
32.49 ^USD	+1.34%		+8.16%	+0.03%

06-14	Global markets live: Tesco, Adobe, Tyson Foods, GameStop, Teva...
06-14	Teva Pharmaceutical Sues Corcept Therapeutics Alleging Market Monopolization for Cushing's Syndrome Drug Korlym	MT

Corcept Therapeutics Insider Sold Shares Worth $1,400,000, According to a Recent SEC Filing	05-16	MT
Corcept Therapeutics Insider Sold Shares Worth $430,475, According to a Recent SEC Filing	03-21	MT
Corcept Therapeutics Incorporated Appoints Roberto Vieira as President, Oncology	01-29	CI
Corcept Therapeutics Insider Sold Shares Worth $320,000, According to a Recent SEC Filing	12-26	MT
Corcept Therapeutics Insider Sold Shares Worth $204,063, According to a Recent SEC Filing	12-07	MT
Corcept Therapeutics Incorporated Appoints Monica Tellado as President, Emerging Markets	11-01	CI
Corcept Therapeutics Insider Sold Shares Worth $504,039, According to a Recent SEC Filing	13/10/23	MT
Insider Sell: Corcept Therapeutics	16/08/23	MT
Insider Sell: Corcept Therapeutics	12/05/23	MT
Insider Sell: Corcept Therapeutics	21/11/22	MT
Insider Sell: Corcept Therapeutics	15/11/22	MT
Insider Sell: Corcept Therapeutics	08/07/22	MT
Insider Sell: Corcept Therapeutics	08/07/22	MT
Insider Sell: Corcept Therapeutics	19/05/22	MT
Insider Sell: Corcept Therapeutics	16/09/21	MT
Insider Sell: Corcept Therapeutics	03/09/21	MT
Corcept Therapeutics Incorporated Announces Separation of Andreas Grauer as Chief Medical Officer	13/08/21	CI
William Guyer to Join Corcept as Chief Development Officer, Effective August 16, 2021	12/08/21	CI
Corcept Therapeutics Incorporated Appoints Amy Flood as Chief Human Resources and Communications Officer	12/07/21	CI
Insider Trends: 90-Day Buying Trend Prolonged with Insider Purchase of Corcept Therapeutics Stock	16/06/21	MT

No results for this search